Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Monkeypox outbreak
May 23, 2022
Drug Induced Photosensitivity
May 9, 2022
Medical Alert Paraphernalia
February 21, 2022
Advice for patients on long-term steroid treatment
February 21, 2022
Adrenal insufficiency
February 4, 2022
Facemask Anxiety
January 5, 2022
Differences between ABPA and CPA
January 5, 2022
The importance of microbiomes
December 16, 2021
Grieving for the life you once had
December 10, 2021
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video